Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost-Effectiveness of Dimethyl Fumarate Treatment for Relapsing-Remitting Multiple Sclerosis From A Danish Perspective.
Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients.
The carbocyanine dye DiD labels in vitro and in vivo neural stem cells of the subventricular zone as well as myelinated structures following in vivo injection in the lateral ventricle.
What is the optimal sequence of rescue treatments for attacks of NMOSD?
Age-dependent increase of blood-brain barrier permeability and neuron-binding autoantibodies in S100B knockout mice.
Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast.
Assessing humoral immunocompetence after alemtuzumab treatment in MS.
Pharmaceutical approval update.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
[Multiple sclerosis within the Spanish context].
Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network.
Cortical Lesions in Multiple Sclerosis: Clinical Relevance for a Hidden Disease Burden.
Should patients with optic neuritis be treated with steroids?
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management.
Effect Of Fingolimod On Disease Progressions, Relapse Rate And Brain Atrophy In Multiple Sclerosis Patients: Review Of Literature And Pharmacoeconomic Considerations.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
Neural progenitor cells isolated from the subventricular zone present hemichannel activity and form functional gap junctions with glial cells.
Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertion.
Effect of axotomy and 17β-estradiol on P2X7 receptor expression pattern in the hypoglossal nucleus of ovariectomized mice.
A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
Evidence for Borna disease virus infection in neuropsychiatric patients in three western China provinces.
Contrast enhanced MR venography with gadofosveset trisodium: Evaluation of the intracranial and extracranial venous system.
Vitamin D and multiple sclerosis-from epidemiology to prevention.
Are cognitive interventions for Multiple Sclerosis effective and feasible?
Detection of Antibodies against Human and Plant Aquaporins in Patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
634
635
636
637
638
639
640
641
642
…
next ›
last »